Assessing clinical severity in children with sickle cell disease. Preliminary results from a cooperative study.

G L Bray, L Muenz, N Makris, L S Lessin
{"title":"Assessing clinical severity in children with sickle cell disease. Preliminary results from a cooperative study.","authors":"G L Bray,&nbsp;L Muenz,&nbsp;N Makris,&nbsp;L S Lessin","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Although it is clear that sickle cell disease is curable with bone marrow transplantation, there are few objective criteria that are helpful in the identification of suitable candidates for this aggressive and potentially life-threatening procedure. This disease is characterized by a highly variable clinical course, and there is a need to intervene with marrow transplant before the onset of disease-mediated chronic organ damage. These factors high-light the need for a clinical severity index that can prospectively identify patients who are at high risk for a turbulent clinical course and a poor prognosis.</p><p><strong>Patients and methods: </strong>We used the Cooperative Study of Sickle Cell Disease data base to identify features of the disease in early childhood (i.e., < 2 years of age) that are associated either with significant morbidity later in childhood or early mortality. Our study population includes the 1,944 children who entered the study before 12 years of age. Univariate analysis showed that factors associated with the occurrence of cerebrovascular accident (51 patients) include hematocrit, rate of change of pocked red cell count, and polymer fraction at 40% oxygen saturation (PF40). Only low hematocrit was predictive of death in this pediatric cohort (45 disease-related deaths).</p><p><strong>Results: </strong>Our ability to identify other potential factors that correlate with these outcome measures is limited by their small numbers. Hence, it was necessary to designate a different endpoint whose relationship with various clinical and laboratory parameters could be assessed. To accomplish this, a distribution of acute events, which were defined as any episode of pain or acute chest syndrome, was calculated. Also, the age-specific \"expected\" event rate, defined as the mean number of events per patient-year of observation, was determined.</p><p><strong>Conclusions: </strong>The relationship between various aspects of sickle cell disease and high positive deviance from the expected event rate will be assessed in a cohort of 519 children who entered the study prior to 7 months of age and were followed beyond their second birthday.</p>","PeriodicalId":22558,"journal":{"name":"The American journal of pediatric hematology/oncology","volume":"16 1","pages":"50-4"},"PeriodicalIF":0.0000,"publicationDate":"1994-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The American journal of pediatric hematology/oncology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Although it is clear that sickle cell disease is curable with bone marrow transplantation, there are few objective criteria that are helpful in the identification of suitable candidates for this aggressive and potentially life-threatening procedure. This disease is characterized by a highly variable clinical course, and there is a need to intervene with marrow transplant before the onset of disease-mediated chronic organ damage. These factors high-light the need for a clinical severity index that can prospectively identify patients who are at high risk for a turbulent clinical course and a poor prognosis.

Patients and methods: We used the Cooperative Study of Sickle Cell Disease data base to identify features of the disease in early childhood (i.e., < 2 years of age) that are associated either with significant morbidity later in childhood or early mortality. Our study population includes the 1,944 children who entered the study before 12 years of age. Univariate analysis showed that factors associated with the occurrence of cerebrovascular accident (51 patients) include hematocrit, rate of change of pocked red cell count, and polymer fraction at 40% oxygen saturation (PF40). Only low hematocrit was predictive of death in this pediatric cohort (45 disease-related deaths).

Results: Our ability to identify other potential factors that correlate with these outcome measures is limited by their small numbers. Hence, it was necessary to designate a different endpoint whose relationship with various clinical and laboratory parameters could be assessed. To accomplish this, a distribution of acute events, which were defined as any episode of pain or acute chest syndrome, was calculated. Also, the age-specific "expected" event rate, defined as the mean number of events per patient-year of observation, was determined.

Conclusions: The relationship between various aspects of sickle cell disease and high positive deviance from the expected event rate will be assessed in a cohort of 519 children who entered the study prior to 7 months of age and were followed beyond their second birthday.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
评估儿童镰状细胞病的临床严重程度合作研究的初步结果。
目的:虽然镰状细胞病是可以通过骨髓移植治愈的,但很少有客观的标准可以帮助确定这种具有侵袭性和潜在威胁生命的手术的合适人选。这种疾病的特点是临床病程变化很大,在疾病介导的慢性器官损伤发生之前,需要进行骨髓移植干预。这些因素突出了对临床严重程度指数的需求,该指数可以前瞻性地识别处于动荡临床过程高风险和预后不良的患者。患者和方法:我们使用镰状细胞病合作研究数据库来确定儿童早期(即< 2岁)与儿童后期显著发病率或早期死亡率相关的疾病特征。我们的研究人群包括1944名12岁前进入研究的儿童。单因素分析显示脑血管意外(51例)发生的相关因素包括红细胞压积、袋状红细胞计数变化率和40%氧饱和度下的聚合物分数(PF40)。在该儿科队列中,只有低血细胞比容可预测死亡(45例疾病相关死亡)。结果:我们识别与这些结果测量相关的其他潜在因素的能力受到数量少的限制。因此,有必要指定一个不同的终点,其与各种临床和实验室参数的关系可以评估。为了做到这一点,计算了急性事件的分布,定义为任何疼痛或急性胸综合征的发作。此外,确定了特定年龄的“预期”事件发生率,定义为每个患者-年观察的平均事件数。结论:将在519名儿童队列中评估镰状细胞病各方面与预期事件高阳性偏差率之间的关系,这些儿童在7个月前进入研究,并随访至两岁以上。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Increased cytokine levels and abnormal response of myeloid progenitor cells to granulocyte colony-stimulating factor in a case of severe congenital neutropenia. In vitro effects of stem cell factor. Recombinant human granulocyte colony stimulating factor in cyclic neutropenia: use of a new 3-day-a-week regimen. Maternal malignancy involving the products of conception: a report of malignant melanoma and medulloblastoma. Secondary acute promyelocytic leukemia in a child treated with epipodophyllotoxins. Transient abnormal myelopoiesis in Down's syndrome neonates.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1